LLY
Eli Lilly and Company
NYQ
$1,064.15
-18.05
(-1.67%)
Extended · +1.02σ
Grade C
Analyst price target
29 analystsLow
$850.00
Mean
$1215.10
High
$1500.00
Current $1064.15
+14.2% to mean
Recommendation
yfinancebuy
Consensus score 1.74 (1 = strong buy · 5 = strong sell)
Earnings history · actual vs estimate
| Date | EPS actual | EPS est | Surprise |
|---|---|---|---|
| 2026-04-30 | 8.55 | 6.79 | +25.9% |
| 2026-02-04 | 7.54 | 6.91 | +9.1% |
| 2025-10-30 | 7.02 | 5.89 | +19.1% |
| 2025-08-07 | 6.29 | 5.50 | +14.5% |
| 2025-05-01 | 3.06 | 4.11 | -25.6% |
| 2025-02-06 | 4.88 | 5.01 | -2.6% |
| 2024-10-30 | 1.18 | 1.47 | -19.5% |
| 2024-08-08 | 3.92 | 2.77 | +41.7% |
| 2024-04-30 | 2.58 | 2.49 | +3.7% |
| 2024-02-06 | 2.49 | 2.37 | +5.1% |
| 2023-11-02 | 0.10 | -0.12 | +181.5% |
| 2023-08-08 | 2.11 | 1.99 | +5.9% |